|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01518 NC HEALTHCARE
Nominal 
0.900 0.000 (0.000%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 933,073 | 46.604% | 636,459 | 632,565 | 512,785 | 729,369 |
| Cost of Sales | -- | -- | -- | -- | (377,021) | (468,067) |
| Gross Profit | -- | -- | -- | -- | 135,764 | 261,302 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (32,432) | -88.824% | (290,202) | (22,592) | (270,482) | (106) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (80) | 196.296% | (27) | (703) | 54 | (67) | |
| Profit / (Loss) before Taxation | 166,142 | -- | (289,853) | (59,147) | (328,747) | 48,065 | |
| Taxation | (34,053) | 1879.826% | (1,720) | (26,115) | (48,787) | (43,572) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (47,925) | 677.877% | (6,161) | (16,199) | 6,151 | (31,049) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 84,164 | -- | (297,734) | (101,461) | (371,383) | (26,556) | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 5,587 | 68.435% | 3,317 | 13,594 | 20,040 | 14,493 |
| Depreciation & Amortisation | 59,982 | -14.615% | 70,249 | 86,621 | 94,788 | 107,739 |
| Directors' Emoluments | 6,334 | 8.237% | 5,852 | 5,570 | 5,462 | 6,460 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 17.000 | -- | -62.000 | -21.000 | -77.000 | -5.000 |
| DPS (cts) | 3.428 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 20.164% | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.329 | -- | 0.158 | 0.046 | (0.009) | 0.262 |
| NBV per share ($) | 1.066 | -- | 0.894 | 1.505 | 1.711 | 2.471 |
| Remarks: | Real time quote last updated: 29/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 25,193,000 |
| %Change | 9.065% |
| EPS / (LPS) | RMB 0.050 |
| NBV Per Share (¥) | RMB 1.083 |